South Korea has enacted a regulation on synthetic biology, a first globally. The move is expected to impact the development of bioengineering and potentially accelerate drug development, with some reports suggesting a focus on ai-driven approaches. The regulation is part of a broader effort that may include significant investment in related areas, such as bio data infrastructure.